Vivanza inks strategic cooperation for plastic film project in Kyrgyz Republic

Strategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹2.00

prior close

₹1.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-4.7% vs market

Pharmaceuticals peers, median of 165sector+0.1%-5.1% vs sector

On the reaction day the stock moved 4.7 pts less than Nifty Microcap 250 and 5.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0-0.3-4.7+0.1-5.1

Next day

-7.0+0.8-7.8+0.9-7.9

+0.0+0.9-0.9+0.4-0.4

-4.0+1.8-5.8+0.9-4.9

+0.0+1.5-1.5+1.8-1.8

-5.0+1.7-6.7+1.6-6.6

-9.0-1.1-7.9+0.1-9.1

15d

-9.0+1.0-10.0+1.8-10.8

-3.0+0.4-3.4+1.6-4.6

-15.0+6.4-21.4+1.3-16.3

-13.0+5.5-18.5+4.8-17.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vivanza Biosciences signed a non-binding strategic cooperation and technology transfer agreement with Mr. Kalybek Uulu Bekturgan to set up a plastic film manufacturing project in the Kyrgyz Republic. Scope includes technology transfer, machinery sourcing, government liaison, investment facilitation, skill development, import-export support, and financing assistance. No monetary consideration at present. A joint venture is possible later, subject to definitive agreements and approvals.

Likely market impact

Non-binding pact with no immediate financial impact. Long-term, could expand Vivanza's presence in Central Asia if a formal joint venture materializes.